Get the Stockscreener App
201.48
1.97%
3.90
After Hours:
201.48
Icon Plc stock is traded at $201.48, with a volume of 1.13M.
It is up +1.97% in the last 24 hours and up +8.40% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$197.58
Open:
$198.22
24h Volume:
1.13M
Relative Volume:
1.25
Market Cap:
$15.38B
Revenue:
$8.19B
Net Income/Loss:
$758.19M
P/E Ratio:
21.95
EPS:
9.18
Net Cash Flow:
$1.06B
1W Performance:
+10.10%
1M Performance:
+8.40%
6M Performance:
+34.23%
1Y Performance:
-6.51%
1-Day Range:
$197.38
$202.78
1-Week Range:
$181.06
$202.78
52-Week Range:
$125.10
$228.28
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
201.48 | 15.09B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
ICON (ICLR) Is Up 8.0% After Artisan Flags Crisis-Level ValuationHas The Bull Case Changed? - simplywall.st
ICON plc Is Quietly Eating Wall Street: Is ICLR the Undervalued Game-Changer No One On TikTok Knows - AD HOC NEWS
Icon Energy Corp. (ICON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Icon Plc $ICLR Shares Purchased by Ninety One UK Ltd - MarketBeat
Icon Plc $ICLR is Ninety One North America Inc.'s 9th Largest Position - MarketBeat
Eldred Rock Partners LLC Grows Stock Holdings in Icon Plc $ICLR - MarketBeat
Leerink Partners reiterates Outperform rating on ICON stock with $220 target - Investing.com UK
Allspring Global Investments Holdings LLC Grows Stake in Icon Plc $ICLR - MarketBeat
Farmers & Merchants Investments Inc. Trims Stock Position in Icon Plc $ICLR - MarketBeat
Live Oak Private Wealth LLC Buys 5,593 Shares of Icon Plc $ICLR - MarketBeat
Rice Hall James & Associates LLC Purchases 9,889 Shares of Icon Plc $ICLR - MarketBeat
Swedbank AB Buys 6,300 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc (ICLR) Stock Price History & Data - Traders Union
Coho Partners Ltd. Has $26.69 Million Stock Holdings in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by LVM Capital Management Ltd. MI - MarketBeat
Corient Private Wealth LLC Sells 17,925 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc (NASDAQ:ICLR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Here’s Why ICON Plc. (ICLR) Gained +20.3% in Q3 - Insider Monkey
BofA Securities downgrades ICON stock rating to Neutral on 2026 growth concerns By Investing.com - Investing.com South Africa
BofA Securities downgrades ICON stock rating to Neutral on 2026 growth concerns - Investing.com UK
BofA Securities Downgrades Icon PLC(ICLR.US) to Hold Rating, Announces Target Price $195 - 富途牛牛
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛
Icon Plc $ICLR Shares Bought by Liontrust Investment Partners LLP - MarketBeat
Lazard Asset Management LLC Sells 308,092 Shares of Icon Plc $ICLR - MarketBeat
Neuberger Berman Group LLC Sells 553,413 Shares of Icon Plc $ICLR - MarketBeat
193,000 Shares in Icon Plc $ICLR Purchased by Hudson Bay Capital Management LP - MarketBeat
Icon Plc $ICLR Shares Bought by Holocene Advisors LP - MarketBeat
75,000 Shares in Icon Plc $ICLR Bought by Hound Partners LLC - MarketBeat
Hudson Bay Capital Management LP Makes New $28.07 Million Investment in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Headlands Technologies LLC - MarketBeat
Icon Plc $ICLR Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Bamco Inc. NY Lowers Position in Icon Plc $ICLR - MarketBeat
Boone Capital Management LLC Invests $13.94 Million in Icon Plc $ICLR - MarketBeat
Sei Investments Co. Acquires 309,635 Shares of Icon Plc $ICLR - MarketBeat
300,000 Shares in Icon Plc $ICLR Purchased by Camber Capital Management LP - MarketBeat
California Public Employees Retirement System Has $22.55 Million Stock Position in Icon Plc $ICLR - MarketBeat
Axa S.A. Cuts Stock Position in Icon Plc $ICLR - MarketBeat
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Icon Plc $ICLR Shares Bought by Qube Research & Technologies Ltd - MarketBeat
Amundi Sells 7,228 Shares of Icon Plc $ICLR - MarketBeat
How Investors May Respond To ICON (ICLR) Surveying AI‑Driven R&D Resilience And Bottlenecks In Biotech - Sahm
ICON plc Releases Findings from Two Biotech Sector Survey - marketscreener.com
Here’s How ICON plc (ICLR) Recovered from Challenges - Insider Monkey
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive - Business Wire
Icon Plc $ICLR Shares Sold by M&T Bank Corp - MarketBeat
Fayez Sarofim & Co Has $13.72 Million Holdings in Icon Plc $ICLR - MarketBeat
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛
Kennedy Capital Management LLC Sells 10,424 Shares of Icon Plc $ICLR - MarketBeat
Brant Point Investment Management LLC Sells 7,000 Shares of Icon Plc $ICLR - MarketBeat
Brown Advisory Inc. Buys 17,717 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):